Transcription
Rob HallfordAssociate DirectorDuke UniversityOffice of Licensing & Venturesolv.duke.edu
CommercialOpportunity
Intellectual property Commercialization Office of Licensing & Ventures
Protecting Innovation
PatentCopyrightTrademark
Description of an inventionreduced to practiceInventor provides: detailedinstructions on ―how to‖Government provides:commercial protection
To be patentable, an invention must be: Novel – some aspect must be new Non-obvious Useful Of patentable subject matter Undisclosed When in doubt, let us check it out
Patentable inventions: Compositions of matter Methods of use Methods of making Apparatus Patent relationships: Dominance Mutual exclusion
An invention is disclosed when enablinginformation is: Verbally presented or discussed Put into print Posted online An inventor is one who contributes, in aninventive manner, to at least one claim Would the claimed invention exist? Ideas incorporated vs. not incorporated
ClaimsEnforcement and jurisdictionPatent rights—protection
Priority DateBar Date
Maximizing Impact
Passion for a particular fieldIntellectual curiosityDesire to find and share knowledgeDesire to improve human condition
Typical Drug Development Costs: 1.0 BTypical Number of Duke Drug Licenses: 10/yrEntirety of Duke University Endowment: 4.8 BCommercial partners are critical inRealizing benefits of research
Licensee (partner): obtains right topractice under patentLicensor (Duke): CompensationPatent ownershipInventor (PI): Retained rights to practiceResearch fundsRevenue share
DiagnosticAdvanced Liquid LogicAldagen (formerly STEMCO Biomedical)BioptigenCenticeExpression AnalysisReproductive Health TechnologyDrug DeliveryAffinergyMerix BiosciencePhase BioscienceRegado BiosciencesSynergy VaccinesHardware / Software / ITAdvanced Liquid LogicBright View TechnologiesMBright, SentillionTherapeutics / BioTechAngiomicsB3BioCellective TherapeuticsChaperone TherapeuticsFibroGenHumacyteNitroxPrecision BiosciencesReproductive Health TechnologyTrimerisTrevenaTherapeutics / PharmaceuticalAerie PharmaceuticalsBradmer, MicroIsletOrexigenVenture ServicesSoutheast TechInventuresSyneCor
Net Revenue 500K*Net Revenue 500K - 2000K*Net Revenue 2000K*Inventor50%33%25%Inventor Lab10%15%15%Inventor Dept10%15%15%OLV10%10%10%University Rsch20%20%20%7%5%Inventor SchoolGrad/Post DocRsch* After patent expenses are paid10%
Delays publication?Restricts scientific discovery?At odds with academic mission?Viewed as materialistic?
Bayh-DolePasses
All inventions must be disclosed Not necessarily University-owned Disclosure is confidential Forms: olv.duke.edu/inventors/forms University-owned inventions come from: University research Scope of inventor’s employment University time, facilities, staff, etc.
Inventors IP assessment Partners License & option Marketassessment Patent filing &management Governmentcompliance Financialmanagement gStart-up formationInnovation mining
Rose opalakrishnanRobHallfordAssociate Directors, DozierKeith GoellerGeorge YachanWilliam TateDeborah GorntoCora GreeneJudy WilkinsonGary WilkinsonSam ChristieEric PatentsOLV is one part of Duke University’s Corporate and VentureDevelopment, under Dr. Robert Taber, Vice Chancellor
Amy Collinsworth,PhDOrthopedics, Stem Cells, Pharma tools (biochipsand manufacturing support), sensors & controlsystemsBryan Baines, RPhOncology, Pulmonary/Asthma, genomicsDennis Thomas, PhDOphthalmology, Infectious Disease, Organ diseases,AgricultureRob Hallford, MS, MBAMetabolism/Nutrition/Diet, software, biomarkersHenry Berger, PhDBrain machine interface, non-disease specific drugdelivery, internet/computers, electronicmaterials/semiconductors, imagingdevice/equipment, transportation/environmentKarthikGopalakrishnan, PhDImmunology, Neuroscience, Imaging Chemistry,Psychiatric Disease, Cardiovascular
Associate Director,Office of Licensing & Ventures919-681-7579rob.hallford@duke.edu
MBright, Sentillion Therapeutics / BioTech Angiomics B3Bio Cellective Therapeutics Chaperone Therapeutics FibroGen Humacyte Nitrox Precision Biosciences Reproductive Health Technology Trimeris Trevena Therapeutics / Pharmaceutical Aerie Pharmaceuticals Bradmer, MicroIslet Orexigen Venture Services
